Clinical Trials
13
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.
- Conditions
- SepsisAcute Infection
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- MeMed Diagnostics Ltd.
- Target Recruit Count
- 2000
- Registration Number
- NCT06665542
- Locations
- 🇺🇸
Maimonides MC, New York, New York, United States
🇺🇸MCW, Milwaukee, Wisconsin, United States
🇮🇱Carmel MC, Haifa, Israel
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)
- Conditions
- Lower Respiratory Tract Infection
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- MeMed Diagnostics Ltd.
- Target Recruit Count
- 1316
- Registration Number
- NCT05762302
- Locations
- 🇺🇸
University of Florida-Jacksonville, Jacksonville, Florida, United States
🇺🇸University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸Maimonides Medical Center, Brooklyn, New York, United States
Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)
- Conditions
- Acute Infection
- First Posted Date
- 2022-06-30
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- MeMed Diagnostics Ltd.
- Target Recruit Count
- 215
- Registration Number
- NCT05439551
- Locations
- 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States
🇺🇸Urgent Care Clinical Trials @ AFC Urgent Care- Easley, Easley, South Carolina, United States
🇮🇱Hillel Yaffe Medical Center, Hadera, Israel
Establish MeMed BV™ Performance for Differentiating Bacterial From Viral Infection in Suspected Acute Infection Patients (APOLLO STUDY)
- Conditions
- Acute Infection
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- MeMed Diagnostics Ltd.
- Target Recruit Count
- 1384
- Registration Number
- NCT04690569
- Locations
- 🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸Maimonides Medical Center, New York, New York, United States
Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients
- Conditions
- COVID-19
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2020-05-15
- Lead Sponsor
- MeMed Diagnostics Ltd.
- Target Recruit Count
- 52
- Registration Number
- NCT04389645
- Locations
- 🇮🇱
Rabin Medical Center, Petach Tikva, Israel
- Prev
- 1
- 2
- 3
- Next